Intelligence · Patents
Patents expiring in 2030
Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.
- Patents
- 905
Quick answer
905 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7767816
Azaindoles useful as inhibitors of janus kinases
granted -
US 7767717
Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
granted -
US 7767784
Methods for preparing polymeric reagents and compositions of polymeric reagents
granted -
US 7767672
Aminopyrimidines useful as kinase inhibitors
granted -
US 7767665
1,3-benzothiazinone derivatives and use thereof
granted -
US 7767680
Ion channel modulators and methods of use
granted -
US 7767429
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
granted -
US 7767216
Antimicrobial compositions and methods of use
granted -
US 7767210
RNA virus vaccines and methods
granted -
US 7767303
Cleaning article containing hydrophilic polymers
granted -
US 7767686
Method of using adenosine receptor blockers during tissue ablation
granted -
US 7767645
SH2 domain binding inhibitors
granted -
US 7767689
Carboline derivatives useful in the treatment of cancer
granted -
US 2010197640
NOVEL SULFAMOYL-PHENYL-UREIDO COMPOUNDS AND THEIR USE AS MEDICAMENT
granted -
US 7771732
Polymer network compositions and associated methods
granted -
US 7771963
Methods for determining efficacy of chemotherapeutic agents
granted -
US 7772188
Methods and compositions for the treatment of gastrointestinal disorders
granted -
US 7772192
Compositions and methods for treatment of disease with acetylated disaccharides
granted -
US 7772239
Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists
granted -
US 7772250
Compounds
granted -
US 7772230
Chroman compound, processes for its preparation, and its pharmaceutical use
granted -
US 7771956
Method for detecting the presence of a phospholipid
granted -
US 7771729
Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors
granted -
US 7772200
iRNA agents targeted to the Rho-A gene
granted -
US 7772219
Methods of hormonal treatment utilizing extended cycle contraceptive regimens
granted -
US 7772387
Oligonucleotides comprising a modified or non-natural nucleobase
granted -
US 7772259
1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
granted -
US 7772434
Crystalline form of a β2 adrenergic receptor agonist
granted -
US 7772370
Antifungal polypeptides
granted -
US 7772271
Methods for treating hepatitis C
granted -
US 7771707
Abuse-deterrent drug formulations
granted -
US 7771715
Recombinant vector expressing multiple costimulatory molecules and uses thereof
granted -
US 7772366
Inhibitors of interleukin-1β converting enzyme
granted -
US 2010204127
USE OF A BOTULINUM NEUROTOXIN TO ALLEVIATE VARIOUS DISORDERS
granted -
US 7776593
Hes6 as a marker of pancreatic endocrine cells
granted -
US 7777077
Dual-acting antihypertensive agents
granted -
US 7777036
Heterocyclic derivatives and their use as therapeutic agents
granted -
US 7777019
Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
granted -
US 7777000
Anti-viral activity of cathelicidin peptides
granted -
US 7776823
Human cathelicidin antimicrobial peptides
granted -
US 7776537
Method of preparing a PRRS virus vaccine
granted -
US 7776320
Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex
granted -
US 7776337
Bacteriocins and novel bacterial strains
granted -
US 7776353
Conjugated linoleic acid compositions
granted -
US 7776361
NELL-1 enhanced bone mineralization
granted -
US 7776365
Article with skin protecting and moisturizing compound
granted -
US 7776521
Coronavirus isolated from humans
granted -
US 7776816
Preserving hypoxic tissue
granted
Frequently asked questions
How many pharma patents expire in 2030?
905 published patents in our USPTO index have expiration dates falling in calendar year 2030.